Real‐world study of next‐generation sequencing diagnostic biomarker testing for patients with lung cancer in Japan

Our previous real‐world studies raised concerns that sequential biomarker testing may lead to increased time to treatment when compared with simultaneous single biomarker testing. The Oncomine Dx target test (ODxTT), a next‐generation sequencing–based multiplex biomarker panel test approved in Japan...

Descripción completa

Detalles Bibliográficos
Autores principales: Takahashi, Toshiaki, Nishio, Makoto, Nishino, Kazumi, Yoshiki, Yasumasa, Shiraiwa, Naoko, Emir, Birol, Iadeluca, Laura, Yatabe, Yasushi, Nishio, Kazuto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
ORIGINAL ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10236614/
https://www.ncbi.nlm.nih.gov/pubmed/36751989
http://dx.doi.org/10.1111/cas.15752

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10236614/
https://www.ncbi.nlm.nih.gov/pubmed/36751989
http://dx.doi.org/10.1111/cas.15752

Ejemplares similares